Mindfulness + tDCS to Reduce Urgency Incontinence in Women

NCT04652869 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 61

Last updated 2024-05-31

Study results available
· View outcomes & findings →

Summary

Urge urinary incontinence (UUI) is a common problem in older women, which vastly reduces quality of life. UUI sufferers frequently report situational triggers (e.g. approaching the front door) leading to urinary urgency and/or leakage, which can be caused by psychological conditioning. This project will test the feasibility, acceptability, and efficacy of brief mindfulness (MI) and non-invasive brain stimulation (transcranial direct current stimulation; tDCS) to reduce reactivity to personal urgency cues and attenuate symptoms of UUI. This is a novel step towards providing personalized efficacious non-pharmacologic treatment for UUI.

Conditions

  • Urinary Incontinence, Urge

Interventions

DEVICE

Transcranial direct current stimulation

Transcranial direct current stimulation targeting the dorsolateral prefrontal cortex

BEHAVIORAL

Mindfulness

Mindfulness is a type of meditation in which you focus on being intensely aware of what you're sensing and feeling in the moment, without interpretation or judgment.

Sponsors & Collaborators

  • National Institute on Aging (NIA)

    collaborator NIH
  • Cynthia Conklin

    lead OTHER

Principal Investigators

  • Cynthia Conklin, PhD · University of Pittsburgh

  • Becky Clarkson, PhD · University of Pittsburgh

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
40 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-05-21
Primary Completion
2023-02-03
Completion
2023-02-10
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04652869 on ClinicalTrials.gov